Value of the serum estradiol level for preventing ovarian hyperstimulation syndrome: A retrospective case control study

Fertility and Sterility

Volumn 81, Issue 2, 2004, Pages 332-336

  D'Angelo, Arianna ^a   Davies, Rachel ^a   Salah, Emad ^a   Nix, Barry A ^a   Amso, Nazar N ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Assisted reproduction; ICSI; IVF; OHSS; Serum estradiol level

Indexed keywords

ESTRADIOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; UNIVERSITY HOSPITAL;

EID: 1242351570     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2003.06.016     Document Type: Article

References (16)

1. Forman R.G., Frydman R., Egan D., Ross C., Barlow D.H. Severe ovarian hyperstimulation syndrome using agonists of gonadotropin releasing hormone for in vitro fertilization a European series and a proposal for prevention . Fertil Steril. 53:1990;502-509.
2. Rabau E., Serr D.M., David A., Maschiac S., Lunenfield B. Human menopausal gonadotropins for anovulation and sterility. Am J Obstet Gynaecol. 98:1967;92-98.
3. Navot D., Bergh P.A., Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies prevention and treatment . Fertil Steril. 58:1992;249-261.
4. Rizk B. Ovarian hyperstimulation syndrome. Brinsden P.R., Rainsbury P.A. Textbook of in vitro fertilization and assisted fertilization. 1992;Parthenon Publishing Group, New Jersey.
5. Tsirigotis M., Craft I. Ovarian hyperstimuation syndrome (OHSS) how much do we really know about it? E J Obstet Gynaecol. 55:1994;151-155.
6. Goldsman M.P., Pedram A., Dominiguez C.E., Ciuffardi I., Levin E., Asch R.H. Increased capillary permeability induced by human follicular fluid a hypothesis for an ovarian origin of the hyperstimulation syndrome . Fertil Steril. 63:1995;268-272.
7. Amso N.N., Ahuja K.K., Morris N., Shaw R.W. The management of predicted ovarian hyperstimulation involving gonadotropin-releasing hormone analog with elective cryopreservation of all pre-embryos. Fertil Steril. 53:1990;1087-1090.
8. Sher G., Salem R., Feinman M., Dodge S., Zouves C., Knutzen V. Eliminating the risk of life-endangering complications following overstimulation with menotropin fertility agents a report on women undergoing in vitro fertilization and embryo transfer . Obstet Gynaecol. 81:1993;1009-1011.
9. Asch R.H., Ivery G., Goldsman M., Frederick J.L., Stone S.C., Balmaceda J.P. The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome. Hum Reprod. 8:1993;1015-1020.
10. Ben-Rafael Z., Levy T., Schoemaker J. Pharmacokinesis of follicle stimulating hormone clinical significance . Fertil Steril. 63:1995;689-700.
11. Golan A., Ron-El R., Herman A., Soffer Y., Wainraub Z., Caspi E. Ovarian hyperstimulation syndrome an update review . Obstet Gynaecol Surv. 44:1989;430-440.
12. Wada I., Matson P.L., Troup S.A., Erard P., Wisanto A., Van Steirteghem A.C. Ovarian hyperstimulation syndrome in GnRH-a/hMG cycles for IVF and GIFT. J Obstet Gynaecol. 11:1990;88-89.
13. Delvigne A., Vandromme J., Barlow P., Lejeune B., Leroy F. Are there predictive criteria of complicates ovarian hyperstimulation in IVF? Hum Reprod. 6:1991;959-962.
14. Morris R.S., Paulson R.J., Sauer M.V., Lobo R.A. Predictive value of serum estradiol concentrations and oocyte number in severe ovarian hyperstimulation syndrome. Hum Reprod. 10:1995;811-814.
15. D'Angelo A., Amso N.N. Embryo freezing for preventing ovarian hyperstimulation syndrome a Cochrane review . Hum Reprod. 17:2002;2787-2794.
16. D'Angelo A, Amso NN. "Coasting" (withholding gonadotropins) for preventing ovarian hyperstimulation syndrome. Cochrane Library, 3, 2002.